Ameritas Investment Partners, Inc. V Tv Therapeutics Inc. Transaction History

Ameritas Investment Partners, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 06, 2021	SELL	$2.27 - $3.44 $1,945 - $2,948	-857 Closed	0 $0
Q2 2020 Aug 05, 2020	BUY	$1.74 - $3.19 $1,491 - $2,733	857 New	857 $2,000
Q2 2018 Aug 13, 2018	SELL	$0.71 - $4.04 $355 - $2,020	-500 Closed	0 $0
Q2 2017 Aug 15, 2017	BUY	N/A	500	500 $2,000

243K

Ticker VTVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 81,483,600
Market Cap $1.07B
Description
vTv Therapeutics Inc., a clinical-stage biopharmaceutical company, focuses on the development of orally administered treatments for diabetes. The company is developing TTP399, an orally administered, small molecule, and liver-selective glucokinase activator for the treatment of type 1 diabetes; and HPP737, an orally administered non-CNS penetran...

Get notified when there are updates to the investment portfolio of Ameritas Investment Partners, Inc., based on Form 13F filings with the SEC.

Stay updated on Ameritas Investment Partners, Inc. with notifications on news.